The market seems to have misjudged MMED MiniMed Group, Inc., as its current valuation starkly contrasts with its DCF Value. The Forward P/E of 6.45 suggests optimism for future earnings, yet the negative Earnings Yield and lack of an Altman Z-score raise red flags about its financial stability. Despite a promising EPS estimate for next year, the company’s current negative ROIC and operating margin indicate inefficiencies. Investors should be wary of the disconnect between the stock’s pricing and its intrinsic value, as the market may be overly optimistic about its turnaround potential.